VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

BAKER BROS. ADVISORS LP's Holding History (CIK: 0001263508)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 1,691,530 Value ($000) $18,996 Avg Close — Range —
Q1 2025
Shares 1,691,530 Value ($000) $7,730 Avg Close — Range —
Q4 2024
Shares 1,691,530 Value ($000) $9,540 Avg Close — Range —
Q3 2024
Shares 1,691,530 Value ($000) $8,187 Avg Close — Range —
Q2 2024
Shares 1,691,530 Value ($000) $8,255 Avg Close — Range —
Q1 2024
Shares 1,691,530 Value ($000) $22,464 Avg Close — Range —
Q4 2023
Shares 1,691,530 Value ($000) $23,580 Avg Close — Range —
Q3 2023
Shares 1,416,530 Value ($000) $18,783 Avg Close — Range —
Q2 2023
Shares 1,416,530 Value ($000) $26,560 Avg Close — Range —
Q1 2023
Shares 1,416,530 Value ($000) $20,426 Avg Close — Range —
Q4 2022
Shares 1,416,530 Value ($000) $27,410 Avg Close — Range —
Q3 2022
Shares 1,416,530 Value ($000) $48,658 Avg Close — Range —
Q2 2022
Shares 1,416,530 Value ($000) $21,645 Avg Close — Range —
Q1 2022
Shares 1,416,530 Value ($000) $32,325 Avg Close — Range —
Q4 2021
Shares 1,416,530 Value ($000) $52,227 Avg Close — Range —
Q3 2021
Shares 1,416,530 Value ($000) $66,577 Avg Close — Range —
Q2 2021
Shares 1,416,530 Value ($000) $85,346 Avg Close — Range —